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ConcentrationAbstract Purpose: To compare the efficacy and reproducibility of black blood T2* to the conven-
tional bright blood sequence in the assessment of myocardial iron concentration.
Materials and methods: We performed both conventional bright blood and black blood MRI T2*
sequences in 50 thalassemia major patients, the results were statistically analyzed to assess the
correlation of techniques, study reproducibility and interobserver agreement.
Results: Cardiac T2* values ranged from 2.39 to 47.9 ms using bright blood sequence and 2.07 to
46.81 using the black blood sequence. There was positive significant correlation of both sequences in
all patients. However the black blood technique was superior to bright blood technique as regards
the study reproducibility (R2*1.9 ± versus 2.4 ± 14.7 p< 0.001) in addition to the better
inter-observer agreement of black blood technique compared to the bright blood technique
(3.2 ± 1.2 versus 8.3 ± 2.4 p< 0.001).
Conclusions: Black blood T2* technique provides clearly defined septal borders, avoids bright
blood signal contamination of the myocardium, has superior study reproducibility and inter-
observer agreement which favors this technique in the assessment of iron myocardial concentration.
 2016 The Egyptian Society of Radiology andNuclearMedicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Patients of thalassemia major on regular blood transfusions
suffer from inevitable accumulation of iron in tissues of the
heart, liver, and endocrine systems. Myocardial iron deposi-
tion resulting in cardiac failure and death at a young age. Early
detection and assessment of myocardial iron is crucial to
Table 1 Age and sex distribution of 50 patients.
Characteristics Patient
N= 50 %
Gender
Male 28 56
Female 22 44
Mean ± ST. deviation
Age
Range 8–41
Mean ± ST. deviation 23.38 + 8.8
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priate iron chelating treatment (1).
Despite the fact that transfusions improve health and sur-
vival, however the consequent tissue iron deposition causes
organ damage in the long term. Patients treated with regular
blood transfusions usually die early from cardiac failure
secondary to myocardial siderosis (2).
Cardiomyopathy can be treated if intensive iron chelation
treatment is initiated properly (3), but diagnosis is often
delayed by the concealed cardiac iron deposition and the late
development of symptoms, and echocardiographic abnormali-
ties (4). Once heart failure develops, the prognosis is usually
poor with abrupt deterioration and death, even with intensive
chelation therapy (5).
Early diagnosis and measurement of myocardial iron depo-
sition would allow proper management and help to reduce
mortality from this reversible cardiomyopathy; however,
endomyocardial biopsy is inaccurate for measuring myocardial
iron because of high rate of sampling error with very small
biopsy samples (6,15).
The need for an alternative noninvasive measurement of
myocardial iron led to the development of an optimized
cardiac T2* magnetic resonance (MR) technique (7).
Intracellular iron particles deposition causes shortening of
the MR relaxation parameter T2* with increase in its recipro-
cal, R2* due to microscopic magnetic field in-homogeneity.
T2* decay is measured by gradient echo CMR, and iron
overload is diagnosed when the values are less than 20 ms
(8). Recently, single breath-hold sequence was evolved with
shorter scan time, better image registration between images,
and excellent reported reproducibility (9). This technique has
become the standard for myocardial iron concentration assess-
ment and has also proved value in the assessment of chelation
regimens (10).
The white blood technique, however, has some undesirable
characteristics including poor contrast between blood pool and
myocardial margins, motion artifacts and blood flow compro-
mising measurement accuracy. Recently, a black blood’ double
inversion recovery sequence which suppresses the blood signal,
has reported a preliminary good reproducibility compared to
the white blood T2* imaging technique (11).
2. Objectives
Our study aimed to compare the efficacy and the technical
reproducibility of black blood T2* and the conventional bright
blood sequence in the assessment of myocardial iron
concentration.
3. Patients and methods
A prospective two-year study of 50 patients on regular blood
transfusion, referred for MRI assessment of cardiac siderosis
has undergone an imaging protocol which includes measure-
ment of cardiac T2* using pulse sequences without and with
a blood suppression prepulse to evaluate interstudy
reproducibility.
All the patients were known TM and were on regular blood
transfusion for more than 18 months. Between the age range 8
and 41 years (mean 27) 56% were male.
17 patients (34%) showed cardiac siderosis (T2* < 20 ms).Our patients were examined by a 1.5 T scanner (Siemens
Espree, Erlangen, Germany) with a 8 channel phased array
cardiac coil and ECG gating.
Three mid-ventricular short axis scans with 6 mm slice
thickness were obtained. For bright blood acquisition, we used
a multi echo gradient sequence (matrix 128  256 pixels, field
of view 40 cm, and flip angle 20). The short axis images were
taken with a single breath-hold (8–12 s) at 8 different echo
times ranged from 2.54 to 17.90 ms at 2 ms increments. Images
of white blood technique were scanned immediately after the
R-wave, while for black blood acquisition, we apply a double
inversion recovery pulse on the R-wave with prolonged inver-
sion time to diastole, that developing 8 increasing echo time
sets of images (12).
We analyze our images using Thalassemia CMR tools (Car-
diovascular Imaging Solutions, London, UK). Our ROI full
thickness section included the ventricular septum but avoiding
the blood pool cavity and cardiac vessels (13,14).
T2* was acquired using an exponential curve fit,
SI = SI0  exp(TE/T2*), and the back ground noise in delayed
echo times was detected in bright blood technique only, and
was removed using the truncation method for better curve
fit. The image quality and the presence of artifacts were
assessed in all sequences.
3.1. Statistical methods
Data were statistically analyzed using SPSS (Statistical Pack-
age for Social Sciences version 20.0). First, the excel file was
imported then full labeling of all variables and their values
were performed with exploration of data for any odd or abnor-
mal values before performing the preliminary analysis.
Line graph was utilized to present the correlation between
bright blood and black blood techniques.
We apply Kaba test in the analysis and the assessment of
image quality and a p value of <0.05 was considered
significant.
4. Results
All 50 patients included in this study had thalassemia major
anemia and were receiving regular blood transfusion. Between
the age range 8 and 41, means SD 23.38 ± 8.8, 28 were males
and 22 females.
Table 1 shows characteristics of the patients (N= 50), show-
ing 56% of the patients aged from 20 to 39 years with Mean
+ SD (23.38 ± 8.8 years). Most of the patients were males.
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bright conventional sequences
Out of 50 patients 33 were normal, while 17 showed varying
degree of myocardial iron concentration: 6 were light, 6 mod-
erate while 5 showed severe iron myocardial concentration.
Table 2 shows that the majority of our patients (33%) were
non cardiac siderosis and only (17%) had severe degree of iron
deposition.
The values of cardiac T2* ranged from 2.39–47.9 ms as
measured with bright blood acquisition and 2.07–46.81 ms
using the black blood sequence.
We reported no significant difference between the mean car-
diac T2* values for all 50 patients using both the black blood
and the conventional bright blood sequences (30.46 ms versus
30.12 ms; p= 0.26).Table 2 Distribution of disease severity among study
population.
Grade (severity) Patients
N= 50 %
Normal 33 66
Light 6 12
Moderate 6 12
Severe 5 10
Table 3 Cardiac T2* values measured by bright and black
blood techniques.
Myocardial iron
concentration (g/ms)
Bright blood Black blood
Normal 29.59–47.95 30.22–46.81
Light 16.30–18.72 16.48–18.11
Moderate 12.45–13.88 12.04–12.67
Severe 2.39–4.56 2.07–4.21
Mean ± SD 30.12 + 14.7 30.46 + 1.47
R 0.99
p value 0.000a
a High significance.
Fig. 1 Shows positive significant correlation bTable 3 and Fig. 1 show the positive significant correlation
between bright and black blood techniques. p value = 0.000.
The black blood and the white blood acquisitions were also
not significant for the iron loaded (N= 17, p= 0.31) and
non-iron loaded (N= 33, p= 0.081) subgroups.
The black blood technique was superior to the bright blood
technique as regards the study reproducibility (R2*1.9 ± 2.07
versus 2.4 ± 14.7) in addition to the better inter-observer
agreement concerning the black blood technique compared
to the bright blood technique (3.2 ± 1.2 versus 8.3 ± 16.4).
4.2. Blood suppression and image quality
Images acquired from midventricular septum using bright- and
black-blood sequences (Fig. 2) show the better delineation of
myocardial septum borders with less artifacts in black blood
T2* images. Blood signal seems contaminating the myocar-
dium in the bright blood image while the myocardium in the
black-blood images is homogeneous.
The analysis of the T2* decay curve and the black blood
T2* sequence showed an improved curve fit compared to the
conventional bright blood sequence (Fig. 3).
In severe iron loaded hearts, the fast signal decay causes the
curve to plateau in delayed echo times. Bright blood technique
(top image) shows the lower points below the level of
background noise (red crosses) causing improper curve fit, so
we used the truncation method in the conventional bright
blood technique (R2 = 0.9983 with truncation). However,
the black blood technique reduced the background noise with
better curve fit through the eight gradual increasing echo
times, without any truncation (R2 = 0.9996) and this
diminishes the analysis errors.
5. Discussion
Iron-overload due to recurrent blood transfusions leading to
heart failure related cardiomyopathy is considered the most
frequent cause of mortality in patients with thalassemia major.
Iron overload is related to repeated blood transfusion, with
each unit of blood containing 200–250 mg of elemental iron,
along with excessive gastrointestinal adsorption. Transfusional
iron is deposited in the reticuloendothelial system (RES); whenetween bright and black blood techniques.
Fig. 2 (a) Bright blood and (b) black blood techniques of short axis midventricular images obtained from the same thalassemia patient
showing the superior image quality and clear septal margins of the black-blood technique.
Fig. 3 Plateau curve in heavily iron loaded heart with rapid decay in the longer echo times. The top image shows the points that fall
below background noise level are removed to improve curve fit (red crosses) using the truncation method for the black blood acquisition,
and in lower image the background noise is reduced and thus the curve fit is complete for the full range of echo times without truncation
which reduces analysis errors.
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accumulate in parenchymal tissues of the endocrine glands,
hepatocytes and myocardium (16,17).
Cardiac MR studies have proved that some thalassemia
major patients have a heterogeneous iron deposition pattern
in the myocardium as measured by in vivo T2*, although with
more and severe cases of iron deposition the heterogeneity
begins to diminish (18).
Myocardial T2* in vivo, however, may be confounded by a
number of factors, including magnetic susceptibility artifact
and measurement error. So in view of these problems, it has
been recommended that T2* measurement should be restricted
to a full-thickness septal ROI, with highly delineative midsep-
tum R2* measurement (19).
Myocardial T2* and functional CMR imaging, are consid-
ered the gold standard for assessment of cardiac iron loading
(20). With continuing advances of MRI technology, main field
non-uniformity is mainly patient-induced and the T2* is sub-
ject to localized susceptibility artifacts (21,22). Fortunately,
the susceptibility artifacts can be minimized by detaining the
measured ROI to the septum, and subsequently, this technique
has demonstrated good reproducibility (23–25) and lately, has
been further optimized in terms of trigger delay, echo-spacing,
acquisition window and other parameters (26).
A more recent advance was the inclusion of black blood
preparation, which provides suppressed blood signal with
clearly defined borders, less motion artifacts leading to supe-
rior reproducibility and improved interobserver agreement
compared to the conventional bright blood GRE sequence
(27).
In this study we included 50 TM patients on regular blood
transfusion, where 17 had varying degree of cardiac siderosis
while 33 were normal as measured with the conventional
bright blood and suppression black blood sequences.
Our study objective was to assess the efficacy and repro-
ducibility of black blood IR technique compared to the con-
ventional bright blood GRE sequence in the assessment of
cardiac iron concentration.
Our results showed positive significant correlation between
the two techniques, with p value 0.000, in agreement with Ou
et al. (28), who stated that, the use of a blood suppression pre-
pulse black blood technique had little effect on the calculated
cardiac R2*.
We reported superior study reproducibility of black blood
T2* imaging in all 50 patients (R2*1.9 ± 2.07 versus 2.4
± 14.7) and in the agreement of the inter-observer variability
(3.2 ± 1.2 versus 8.3 ± 16.4). Similar results were reported by
Smith et al. (29), who found a significant coefficient improve-
ment (three folds) in intra and inter-observer variability with
better inter-study reproducibility for black blood T2* imaging
compared to the conventional white blood sequence.
Using conventional bright blood sequence, resulting in low
signal contrast with difficulty in defining myocardium borders,
hence, the blood contamination will be included in the decay
curve which increases the possibility of errors in T2* measure-
ment. Misregistration of the high signal blood pool artifacts
which can be superimposed on the ROI can also increase the
rate of errors.
Using the double inversion recovery black blood technique
with better delineation of the myocardial borders, and reduc-
ing the noise artifacts will improve the accuracy of T2* mea-
surement (29).Our results showed better image quality, less artifacts and
better delineation of myocardium septum, which improved
decay curve analysis and reduced the requirement for trunca-
tion method in heavily loaded hearts using the black blood
T2* technique, in consistent with Taigang H et al. (30) who
believed that the black-blood T2* technique improved poten-
tial partial volume errors, reduced artifacts and simplified the
data analysis for clinicians and therefore be less sensitive to
observer training errors.
6. Conclusion
Black-blood T2* sequence has improved the assessment of
myocardial iron concentration, by providing high contrast
images, better myocardial border definition, reducing blood
signal contamination from the myocardium and less images
artifacts. We support the use of blood suppression prepulse
for measurement of cardiac T2* based on its superior study
reproducibility and interobserver agreement.
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